Lentigo Maligna

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Lentigo Maligna trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingNot Applicable

NCT07251335

Melanoma of the Skin and Exposure to Solar Ultraviolet Radiation at Work in Modena Territory: a Case-control Study to Pr…

The goal of this observational study is to learn about the link between work-related sun exposure and a specific type of skin cancer called melanoma in people l…

Italy300 participantsStarted 2025-07-07

RecruitingNot Applicable

NCT04068155

Alpha Radiation Emitters Device for the Treatment of of Malignant Cutaneous Tumors

A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for Malignant Cutaneous Tumors

France80 participantsStarted 2022-04-01

Treatment: DaRT- Diffusing Alpha-emitters Radiation Therapy

All recent trials (20 shown)

Active — Not RecruitingPhase 2

NCT00937937

Dinaciclib in Treating Patients With Stage IV Melanoma

This phase II trial is studying the side effects and how well dinaciclib works in treating patients with stage IV melanoma. Dinaciclib may stop the growth of tu…

United States72 participantsStarted 2009-07-01

Treatment: Dinaciclib

CompletedPhase 2

NCT02723721

Prospective Study of Ingenol Mebutate for Non-invasive Lentigo Melanoma of the Face

Non-invasive lentigo maligna (LM) is characterized by an in situ proliferation of melanoma cells, limited to the epidermis. It is found most commonly on the hea…

France20 participantsStarted 2016-06-15

Treatment: Picato gel

Lentigo Maligna

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Melanoma of the Skin and Exposure to Solar Ultraviolet Radiation at Work in Modena Territory: a Case-control Study to Pr…

Alpha Radiation Emitters Device for the Treatment of of Malignant Cutaneous Tumors

All recent trials (20 shown)

Dinaciclib in Treating Patients With Stage IV Melanoma

Prospective Study of Ingenol Mebutate for Non-invasive Lentigo Melanoma of the Face

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Melanoma of the Skin and Exposure to Solar Ultraviolet Radiation at Work in Modena Territory: a Case-control Study to Pr…

Alpha Radiation Emitters Device for the Treatment of of Malignant Cutaneous Tumors

All recent trials (20 shown)

Dinaciclib in Treating Patients With Stage IV Melanoma

Prospective Study of Ingenol Mebutate for Non-invasive Lentigo Melanoma of the Face

Complications and Recurrences After Mohs Micrographic Surgery and Slow Mohs

Comparison of 3 in Vivo Microscopic Imaging Techniques for the Diagnosis of Pigmented Tumors

Radiotherapy or Imiquimod in Complex Lentigo Maligna

Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin Damage

Relevance of Imiquimod as Neo-adjuvant Treatment to Reduce Excision Size and the Risk of Intralesional Excision in Lenti…

Reflectance Confocal Microscopy to Diagnose MM & LM

Imiquimod to Detect Residual Lesions and Prevent Recurrence of Lentigo Maligna

Mohs and Immunofluorescence for Malignant Melanoma In Situ

AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma

Photodynamic Therapy for Lentigo Maligna Using 5-aminolevulinic Acid Nanoemulsion as a Light Sensitizing Cream

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma

Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma

Study of Families With Melanoma

Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna

In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis

Effect of Topical Imiquimod on Lentigo Maligna